2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)

Robert A. Colbert, Atulya (Atul) Deodhar, Muhammad Asim Khan, Rik J. Lories, Walter P. Maksymowych, John D. Reveille, Christopher T. Ritchlin, James (Jim) Rosenbaum, Stephan R. Targan, Michael Weisman, Daniel O. Clegg

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The Spondylarthritis Research and Therapy Network (SPARTAN; www.spartangroup.org) was founded in 2003 by a group of North American clinicians and researchers to promote research, education, and treatment of spondyloarthritis (SpA). In past years, it has produced and disseminated United States-specific modifications of the ASsessments in Ankylosing Spondylitis (ASAS) guidelines for the use of anti-tumor necrosis factor (TNF) therapy in AS1,2. SPARTAN held its fifth annual research meeting in September 2007 in Cleveland, Ohio. Highlights of the meeting included updates on current research in SpA, including epidemiology and genetics, bone formation and inflammation, biomarkers, activation of the IL-23/IL-17 axis, and animal models. A presentation was made on basic and clinical science of inflammatory bowel disease, and an educational pre-meeting conference was specifically designed for rheumatology fellows.

Original languageEnglish (US)
Pages (from-to)1398-1402
Number of pages5
JournalJournal of Rheumatology
Volume35
Issue number7
StatePublished - Jul 2008

Fingerprint

Education
Research
Therapeutics
Spondylarthritis
Interleukin-23
Osteitis
Molecular Epidemiology
Interleukin-17
Ankylosing Spondylitis
Rheumatology
Inflammatory Bowel Diseases
Osteogenesis
Animal Models
Tumor Necrosis Factor-alpha
Biomarkers
Research Personnel
Guidelines

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Colbert, R. A., Deodhar, A. A., Khan, M. A., Lories, R. J., Maksymowych, W. P., Reveille, J. D., ... Clegg, D. O. (2008). 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). Journal of Rheumatology, 35(7), 1398-1402.

2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). / Colbert, Robert A.; Deodhar, Atulya (Atul); Khan, Muhammad Asim; Lories, Rik J.; Maksymowych, Walter P.; Reveille, John D.; Ritchlin, Christopher T.; Rosenbaum, James (Jim); Targan, Stephan R.; Weisman, Michael; Clegg, Daniel O.

In: Journal of Rheumatology, Vol. 35, No. 7, 07.2008, p. 1398-1402.

Research output: Contribution to journalArticle

Colbert, RA, Deodhar, AA, Khan, MA, Lories, RJ, Maksymowych, WP, Reveille, JD, Ritchlin, CT, Rosenbaum, JJ, Targan, SR, Weisman, M & Clegg, DO 2008, '2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)', Journal of Rheumatology, vol. 35, no. 7, pp. 1398-1402.
Colbert RA, Deodhar AA, Khan MA, Lories RJ, Maksymowych WP, Reveille JD et al. 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). Journal of Rheumatology. 2008 Jul;35(7):1398-1402.
Colbert, Robert A. ; Deodhar, Atulya (Atul) ; Khan, Muhammad Asim ; Lories, Rik J. ; Maksymowych, Walter P. ; Reveille, John D. ; Ritchlin, Christopher T. ; Rosenbaum, James (Jim) ; Targan, Stephan R. ; Weisman, Michael ; Clegg, Daniel O. / 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). In: Journal of Rheumatology. 2008 ; Vol. 35, No. 7. pp. 1398-1402.
@article{67eb45755cb54215b5b6384ed3c30257,
title = "2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)",
abstract = "The Spondylarthritis Research and Therapy Network (SPARTAN; www.spartangroup.org) was founded in 2003 by a group of North American clinicians and researchers to promote research, education, and treatment of spondyloarthritis (SpA). In past years, it has produced and disseminated United States-specific modifications of the ASsessments in Ankylosing Spondylitis (ASAS) guidelines for the use of anti-tumor necrosis factor (TNF) therapy in AS1,2. SPARTAN held its fifth annual research meeting in September 2007 in Cleveland, Ohio. Highlights of the meeting included updates on current research in SpA, including epidemiology and genetics, bone formation and inflammation, biomarkers, activation of the IL-23/IL-17 axis, and animal models. A presentation was made on basic and clinical science of inflammatory bowel disease, and an educational pre-meeting conference was specifically designed for rheumatology fellows.",
author = "Colbert, {Robert A.} and Deodhar, {Atulya (Atul)} and Khan, {Muhammad Asim} and Lories, {Rik J.} and Maksymowych, {Walter P.} and Reveille, {John D.} and Ritchlin, {Christopher T.} and Rosenbaum, {James (Jim)} and Targan, {Stephan R.} and Michael Weisman and Clegg, {Daniel O.}",
year = "2008",
month = "7",
language = "English (US)",
volume = "35",
pages = "1398--1402",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "7",

}

TY - JOUR

T1 - 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN)

AU - Colbert, Robert A.

AU - Deodhar, Atulya (Atul)

AU - Khan, Muhammad Asim

AU - Lories, Rik J.

AU - Maksymowych, Walter P.

AU - Reveille, John D.

AU - Ritchlin, Christopher T.

AU - Rosenbaum, James (Jim)

AU - Targan, Stephan R.

AU - Weisman, Michael

AU - Clegg, Daniel O.

PY - 2008/7

Y1 - 2008/7

N2 - The Spondylarthritis Research and Therapy Network (SPARTAN; www.spartangroup.org) was founded in 2003 by a group of North American clinicians and researchers to promote research, education, and treatment of spondyloarthritis (SpA). In past years, it has produced and disseminated United States-specific modifications of the ASsessments in Ankylosing Spondylitis (ASAS) guidelines for the use of anti-tumor necrosis factor (TNF) therapy in AS1,2. SPARTAN held its fifth annual research meeting in September 2007 in Cleveland, Ohio. Highlights of the meeting included updates on current research in SpA, including epidemiology and genetics, bone formation and inflammation, biomarkers, activation of the IL-23/IL-17 axis, and animal models. A presentation was made on basic and clinical science of inflammatory bowel disease, and an educational pre-meeting conference was specifically designed for rheumatology fellows.

AB - The Spondylarthritis Research and Therapy Network (SPARTAN; www.spartangroup.org) was founded in 2003 by a group of North American clinicians and researchers to promote research, education, and treatment of spondyloarthritis (SpA). In past years, it has produced and disseminated United States-specific modifications of the ASsessments in Ankylosing Spondylitis (ASAS) guidelines for the use of anti-tumor necrosis factor (TNF) therapy in AS1,2. SPARTAN held its fifth annual research meeting in September 2007 in Cleveland, Ohio. Highlights of the meeting included updates on current research in SpA, including epidemiology and genetics, bone formation and inflammation, biomarkers, activation of the IL-23/IL-17 axis, and animal models. A presentation was made on basic and clinical science of inflammatory bowel disease, and an educational pre-meeting conference was specifically designed for rheumatology fellows.

UR - http://www.scopus.com/inward/record.url?scp=47349096817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47349096817&partnerID=8YFLogxK

M3 - Article

C2 - 18484685

AN - SCOPUS:47349096817

VL - 35

SP - 1398

EP - 1402

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 7

ER -